Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROMIPLOSTIM Cause Transaminases increased? 12 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Transaminases increased have been filed in association with ROMIPLOSTIM (Nplate). This represents 0.2% of all adverse event reports for ROMIPLOSTIM.

12
Reports of Transaminases increased with ROMIPLOSTIM
0.2%
of all ROMIPLOSTIM reports
3
Deaths
6
Hospitalizations

How Dangerous Is Transaminases increased From ROMIPLOSTIM?

Of the 12 reports, 3 (25.0%) resulted in death, 6 (50.0%) required hospitalization, and 3 (25.0%) were considered life-threatening.

Is Transaminases increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROMIPLOSTIM. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does ROMIPLOSTIM Cause?

Off label use (1,027) Platelet count decreased (892) Platelet count abnormal (703) Drug ineffective (513) Thrombocytopenia (369) Headache (359) Death (356) Product storage error (344) Fatigue (251) Circumstance or information capable of leading to medication error (238)

What Other Drugs Cause Transaminases increased?

METHOTREXATE (1,236) ACETAMINOPHEN (929) ATORVASTATIN (472) RITUXIMAB (448) CYCLOPHOSPHAMIDE (401) PREDNISONE (362) ADALIMUMAB (340) PACLITAXEL (333) ROSUVASTATIN (324) CARBOPLATIN (319)

Which ROMIPLOSTIM Alternatives Have Lower Transaminases increased Risk?

ROMIPLOSTIM vs ROMOSOZUMAB ROMIPLOSTIM vs ROMOSOZUMAB-AQQG ROMIPLOSTIM vs ROPEGINTERFERON ALFA-2B-NJFT ROMIPLOSTIM vs ROPINIROLE ROMIPLOSTIM vs ROPIVACAINE

Related Pages

ROMIPLOSTIM Full Profile All Transaminases increased Reports All Drugs Causing Transaminases increased ROMIPLOSTIM Demographics